126 related articles for article (PubMed ID: 36111354)
1. Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits.
Huang XX; Jiang RH; Xu XQ; Wang W; Sun YQ; Li L; Shi HB; Liu S
Magn Reson Med; 2023 Jan; 89(1):384-395. PubMed ID: 36111354
[TBL] [Abstract][Full Text] [Related]
2. Ischemic Stroke Increased Gadolinium Deposition in the Brain and Aggravated Astrocyte Injury After Gadolinium-Based Contrast Agent Administration: Linear Versus Macrocyclic Agents.
Huang XX; Jiang RH; Xu XQ; Zu QQ; Wu FY; Liu S; Shi HB
J Magn Reson Imaging; 2021 Apr; 53(4):1282-1292. PubMed ID: 33555617
[TBL] [Abstract][Full Text] [Related]
3. Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain.
Anderhalten L; Silva RV; Morr A; Wang S; Smorodchenko A; Saatz J; Traub H; Mueller S; Boehm-Sturm P; Rodriguez-Sillke Y; Kunkel D; Hahndorf J; Paul F; Taupitz M; Sack I; Infante-Duarte C
Invest Radiol; 2022 Oct; 57(10):677-688. PubMed ID: 35467573
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium Retention and Nephrotoxicity in a Mouse Model of Acute Ischemic Stroke: Linear Versus Macrocyclic Agents.
Wang W; Huang XX; Jiang RH; Zhou J; Shi HB; Xu XQ; Wu FY
J Magn Reson Imaging; 2024 May; 59(5):1852-1861. PubMed ID: 37548106
[TBL] [Abstract][Full Text] [Related]
5. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
6. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats.
Bussi S; Coppo A; Bonafè R; Rossi S; Colombo Serra S; Penard L; Kirchin MA; Maisano F; Tedoldi F
J Magn Reson Imaging; 2021 Nov; 54(5):1636-1644. PubMed ID: 33973290
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions.
Boyken J; Frenzel T; Lohrke J; Jost G; Pietsch H
Invest Radiol; 2018 May; 53(5):278-285. PubMed ID: 29319556
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
[TBL] [Abstract][Full Text] [Related]
12. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of the Spatial Distribution of Gadolinium, Iron, Manganese, and Phosphorus in the Brain of Healthy Rats After High-Dose Administrations of Gadodiamide and Gadobutrol.
Hummel L; Frenzel T; Boyken J; Pietsch H; Seeliger E
Invest Radiol; 2024 Feb; 59(2):150-164. PubMed ID: 38157437
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents.
Ringler MD; Rhodes NG; Ayers-Ringler JR; Jakaitis DR; McDonald RJ; Kallmes DF; McDonald JS
Skeletal Radiol; 2021 Jul; 50(7):1419-1425. PubMed ID: 33404669
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
[TBL] [Abstract][Full Text] [Related]
16. The Macrocyclic Gadolinium-Based Contrast Agents Gadobutrol and Gadoteridol Show Similar Elimination Kinetics From the Brain After Repeated Intravenous Injections in Rabbits.
Frenzel T; Ulbrich HF; Pietsch H
Invest Radiol; 2021 Jun; 56(6):341-347. PubMed ID: 33259443
[TBL] [Abstract][Full Text] [Related]
17. Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.
Bussi S; Coppo A; Botteron C; Fraimbault V; Fanizzi A; De Laurentiis E; Colombo Serra S; Kirchin MA; Tedoldi F; Maisano F
J Magn Reson Imaging; 2018 Mar; 47(3):746-752. PubMed ID: 28730643
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry.
Hua N; Minaeva O; Lupoli N; Franz ES; Liu X; Moncaster JA; Babcock KJ; Jara H; Tripodis Y; Guermazi A; Soto JA; Anderson SW; Goldstein LE
Radiology; 2023 Jan; 306(1):244-251. PubMed ID: 36125373
[TBL] [Abstract][Full Text] [Related]
20. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.
Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H
Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
